Expert Opinion on Therapeutic Patents, Volume 19, Issue 6 (2009)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Therapeutic Patents, Volume 19, Issue 6 (2009)

See all volumes and issues
Vol 34, 2024 Vol 33, 2023 Vol 32, 2022 Vol 31, 2021 Vol 30, 2020 Vol 29, 2019 Vol 28, 2018 Vol 27, 2017 Vol 26, 2016 Vol 25, 2015 Vol 24, 2014 Vol 23, 2013 Vol 22, 2012 Vol 21, 2011 Vol 20, 2010 Volume 19, 2009 Vol 18, 2008 Vol 17, 2007 Vol 16, 2006 Vol 15, 2005 Vol 14, 2004 Vol 13, 2003 Vol 12, 2002 Vol 11, 2001 Vol 10, 2000 Vol 9, 1999 Vol 8, 1998 Vol 7, 1997 Vol 6, 1996 Vol 5, 1995 Vol 4, 1994 Vol 3, 1993 Vol 2, 1992 Vol 1, 1991
Download citations Download PDFs Download issue

Reviews

Article
Advances in preclinical small molecules for the treatment of NSCLC
Qiu Zhang, Wei Feng, Hongyu Zhou & Bing Yan
Pages: 731-751
Published online: 21 May 2009
AbstractforAdvances in preclinical small molecules for the treatment of NSCLC | Full Text | References | PDF (935.5 KB)
  • 146 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Therapeutic inhibition of the renin angiotensin aldosterone system
David W Laight
Pages: 753-759
Published online: 21 May 2009
AbstractforTherapeutic inhibition of the renin angiotensin aldosterone system | Full Text | References | PDF (212.9 KB)
  • 129 Views
  • 15 CrossRef citations
  • 0Altmetric
Article
Histone acetyltransferase inhibitors and preclinical studies
Fabio Manzo, Francesco Paolo Tambaro, Antonello Mai & Lucia Altucci
Pages: 761-774
Published online: 26 Apr 2009
AbstractforHistone acetyltransferase inhibitors and preclinical studies | Full Text | References | PDF (1.7 MB)
  • 1388 Views
  • 80 CrossRef citations
  • 0Altmetric
Article
Radiosensitising agents for the radiotherapy of cancer: novel molecularly targeted approaches
Francis Dumont, Anais Altmeyer & Pierre Bischoff
Pages: 775-799
Published online: 21 May 2009
AbstractforRadiosensitising agents for the radiotherapy of cancer: novel molecularly targeted approaches | Full Text | References | PDF (654.9 KB)
  • 341 Views
  • 18 CrossRef citations
  • 0Altmetric
Article
11β-hydroxysteroid dehydrogenase type 1 inhibitors: a review of recent patents
Craig D Boyle & Timothy J Kowalski
Pages: 801-825
Published online: 21 May 2009
Abstractfor11β-hydroxysteroid dehydrogenase type 1 inhibitors: a review of recent patents | Full Text | References | PDF (661 KB)
  • 485 Views
  • 66 CrossRef citations
  • 0Altmetric
Article
Improving antidepressant drugs: update on recently patented compounds
Isabel Rozas
Pages: 827-845
Published online: 28 May 2009
AbstractforImproving antidepressant drugs: update on recently patented compounds | Full Text | References | PDF (455.1 KB)
  • 148 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
Phloroglucinol compounds of therapeutic interest: global patent and technology status
Inder Pal Singh PhD, Jasmeen Sidana MS Pharm, Parikshit Bansal PhD & William J Foley PhD
Pages: 847-866
Published online: 26 Apr 2009
AbstractforPhloroglucinol compounds of therapeutic interest: global patent and technology status | Full Text | References | PDF (497 KB)
  • 488 Views
  • 65 CrossRef citations
  • 0Altmetric

Annotated Patent Selections

Article
Annotated Patent Selections
Pages: 867-884
Published online: 28 May 2009
First Page PreviewforAnnotated Patent Selections | Full Text | PDF (427 KB)
  • 46 Views
  • 0 CrossRef citations
  • 0Altmetric

Patent Evaluations

Article
Azacycloalkane derivatives as inhibitors of delta-9 stearoyl-coenzyme A desaturase
Gang Liu PhD
Pages: 885-891
Published online: 08 Apr 2009
AbstractforAzacycloalkane derivatives as inhibitors of delta-9 stearoyl-coenzyme A desaturase | Full Text | References | PDF (369.1 KB)
  • 52 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
A new class of UDP-3-O-(R-3-hydroxymyristol)-N-acetylglucosamine deacetylase (LpxC) inhibitors for the treatment of Gram-negative infections: PCT application WO 2008027466
Gregory D Cuny PhD
Pages: 893-899
Published online: 08 Apr 2009
AbstractforA new class of UDP-3-O-(R-3-hydroxymyristol)-N-acetylglucosamine deacetylase (LpxC) inhibitors for the treatment of Gram-negative infections: PCT application WO 2008027466 | Full Text | References | PDF (300.9 KB)
  • 253 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
C-9 Alkenylidine bridged macrolides: WO2008061189
Enanta Pharmaceuticals, Inc.
Giovanna Poce, Giulio Cesare Porretta & Mariangela Biava
Pages: 901-906
Published online: 08 Apr 2009
AbstractforC-9 Alkenylidine bridged macrolides: WO2008061189 | Full Text | References | PDF (288.9 KB)
  • 29 Views
  • 1 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Leucine-rich repeat kinase 2 (LRRK2) inhibitors for Parkinson’s disease: a patent review of the literature to date
Margaux Morez et al.
Review Article | Published online: 19 Jul 2024
A patent review of small molecule CDK4/6 inhibitors in the treatment of cancer: 2020–present
Xiaoling Huang et al.
Review Article | Published online: 17 Jul 2024
Progress with polo-like kinase (PLK) inhibitors: a patent review (2018–present)
Shirong Bian et al.
Review Article | Published online: 15 Jul 2024
The therapeutic potential of phosphodiesterase 9 (PDE9) inhibitors: a patent review (2018-present)
Chen Zhang et al.
Review Article | Published online: 9 Jul 2024
View all latest articles